ICER assessed GSK's COPD inhalers, Trelegy Ellipta and Breo Ellipta, for Medicare price negotiations, highlighting their once-daily dosing and comparable net health benefits.

Certain medications commonly used to treat asthma and COPD can damage the environment and worsen respiratory issues. KYW ...

Poor treatment of asthma and COPD puts a huge burden on the NHS. For example, £1 billion is spent on asthma treatment in the UK each year and represents 60,000 to 65,000 hospital admissions. In ...

A high-tech device that can monitor medication use and compliance has been cleared by the FDA for use with AstraZeneca’s Airsupra and Breztri inhalers ... disease (COPD). Sales of Breztri ...

Non-communicable diseases pose a significant global health challenge, requiring preventive measures and lifestyle changes for ...

Hospitalists work hard (not that we have to tell you that!), so celebrating March 6 as National Hospitalist Day is an ideal ...

Specialty pharmacy expands access to an innovative, steroid-free treatment NEW PROVIDENCE, NJ, UNITED STATES, March 3, 2025 /EINPresswire / -- ...

Global survey reveals limited awareness of shingles among adults over 50, highlighting age-related health risks and complications.

A majority of Indians who have the virus causing shingles, a painful age-related disease, are unaware of it. As per the ...

We use cookies and other tracking technologies to improve your browsing experience on our website, to show you personalized content and targeted ads, to analyze our website traffic, and to understand ...

Share on Pinterest Getty Images/Evgeniia Siiankovskaia Like regular ... enough to help people reduce their use of anti-inflammatory medications. By the end of the study, 39% of those who took ...